INS and type 2 diabetes mellitus: In contrast to T2DM, which is a relative insulin deficient state with the pathology attributed largely to insulin resistance, it is a defect in insulin secretion that is the principal pathology of both HNF1A-MODY mutation carriers and T1DM [41].